portal vein
美 
英
英漢雙解
1. | 門靜脈a vein that takes blood from the stomach and other organs near the stomach to the liver |
英漢解釋
英英解釋
例句
Enoxaparin, "could become an important treatment for patients at high risk of portal vein thrombosis, " he said.
依諾肝素，“有可能成為一個重要的治療門靜脈血栓形成的高風險患者，”他說。
The primary endpoint was the occurrence of portal vein thrombosis, while secondary endpoints were survival and decompensation, Villa said.
主要終點是門靜脈血栓形成的發生，而次要終點是生存和失代償，比利亞說。
abstract: Portal hypertension(PH) refers to a common digestive system disease with elevated blood flow pressure in the portal vein.
門靜脈高壓癥是消化系統常見病，指門靜脈血流壓力增高。
Background: Serum- ascitic albumin gradient (SAAG) is an indirect parameter reflecting the portal vein pressure.
背景：血清-腹水白蛋白梯度（SAAG）是間接反映門靜脈壓力的指標。
Objective To investigate the relationship between portal vein thrombosis and post-splenectomy fever in patients with portal hypertension.
目的探討脾切除術后門靜脈血栓形成與持續發熱的關系。
Another recent hepatic portal vein and no removal, transportation of anhydrous ethanol injection treatment.
另一個近肝門靜脈，沒有切除，行無水酒精注射處理。
The results showed: (1 ) Blood flow velocity in portal vein when the initial peroid had a higher than those of the normal controls.
結果示：（1）急、慢性肝炎在發病初期的門靜脈平均血流速度均顯著高于對照組，治療后均降低，與治療前比較有意義；
portal vein; cavernous transformation; magnetic resonance imaging; MR angiography.
門靜脈；海綿樣變；磁共振成像；磁共振血管造影。
Objective To investigate the influence of sP-selectin on portal vein thrombosis(PVT) after portal hypertension surgery in liver cirrhosis .
目的探討可溶性P-選擇素對肝硬化門靜脈高壓癥術后門靜脈血栓形成的影響。
The hepatic middle fissure was shallow, among which there was few communicating branch of portal vein .
肝中裂較淺，但其間少有門靜脈交通支存在。
MAIN OUTCOME MEASURES: Occurrence of branches of hepatic portal vein; clearness and satiation of the vessel wall.
主要觀察指標：門靜脈的各級分支的出現以及管壁清晰度、飽滿度。
Pedicle vascular injury included left hepatic artery injury, right hepatic artery, left-portal vein and right-portal vein injury.
肝蒂血管損傷包括肝左、右動脈及門靜脈左、右支損傷。
Portal vein transplantation benefits more than caudal vein transplantation.
門靜脈移植途徑較尾靜脈途徑療效更顯著。
Preliminary survival observation on percutaneous portal vein chronomodulated chemotherapy on treatment of liver cancer .
肝癌經皮門靜脈時辰化療生存期的初步觀察。
Objective: To summarize the nursing methods on percutaneous injection treatment of portal vein tumor thrombus.
目的：總結經皮穿刺門靜脈癌栓內注藥治療門靜脈癌栓的護理措施。
Liver cirrhosis portal vein high pressure existence serious portal vein system blood stream dynamics disorder.
肝硬化門靜脈高壓存在嚴重的門靜脈系統血流動力學紊亂。
Conclusion Ultrasound plays an important role in diagnosing portal vein thrombosis after splenectomy.
結論超聲對脾切除術后門靜脈系統血栓形成患者有很重要的診斷價值。
Serum HGF concentrations were positively correlated with tumor stage, tumor size, portal vein tumor thrombus.
影響術前血清HGF水平的主要因素有：腫瘤分期、腫瘤大小以及門靜脈癌栓。
Conclusion The human hepatic portal vein system possibly is close related with the Chong Vessel.
結論：人體肝門靜脈系可能與經絡沖脈密切相關。
It is not an absolute contraindication of curative resection for those patients with tumor involving portal vein.
門靜脈受浸潤不是根治性切除的絕對禁忌證。
The portal vein system blood flow reduced significantly after iontophoresis of chinese herbal medicine.
中藥離子導入治療后門脈系統血流量明顯減少。
Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.
放射介入栓塞化療對肝癌合并門靜脈癌栓治療的療效觀察。
Conclusions HIU in combination with ADM is safe and effective for treating implanted portal vein tumor thrombus of rabbits.
結論HIU聯合抗癌藥物能夠較為安全有效地治療兔門靜脈癌栓。
Results Among the 12 cases of portal vein thrombosis after splenectomy, the detective rate by ultrasound was 100%.
結果12例脾切除術后門靜脈系統血栓形成患者超聲檢查診斷符合率達100%。
Objective: Discusses colored Doppler supersonic to the liver portal vein lump diagnosis value.
前言：目的：探討彩色多普勒超聲對肝臟門靜脈瘤的診斷價值。
Objective To investigate the characteristic of portal vein in the colorectal cancer with liver metastasis.
目的探討大腸癌伴轉移性肝癌的門靜脈的特點。
Objective To review the advancement of surgical therapy for cavernous transformation of portal vein.
目的介紹門靜脈海綿樣變性外科治療的研究進展。
Objective: Researching the effect of applying selective portal vein embolization(SPVE) in the primary hepatic carcinoma patients.
目的：研究選擇性門靜脈栓塞術（SPVE）在原發性肝癌治療中的作用。
Hepatic artery and portal vein regional infusion chemotherapy can be used as conventional method to prevent recurrence after operation.
肝動脈、門靜脈雙途徑區域灌注化療操作安全有效，可同時用于治療和監測，可作為術后預防復發的常規方法；
Objective To evaluate the diagnostic value of ultrasound in portal vein thrombosis after splenectomy.
目的評價超聲檢查對脾切除術后門脈系統血栓形成的診斷價值。
Hepatic infarction is a rare disease due to dual blood supply from the hepatic artery and the portal vein.
由于有肝動脈及肝門靜脈供應肝臟血流，因此肝梗塞是相當罕見。
Objective To evaluate the safety and efficacy of selective portal vein embolization(SPVE) with ZT glue in rabbit.
目的探討ZT膠行兔選擇性門靜脈栓塞（SPVE）的安全性及有效性。
Hypertension in the portal vein system is a key pathophysiological factor of progressing cirrhosis of the liver.
在門靜脈系統高血壓是一個重要的進展是肝硬化的病理生理因素。
Portal vein thrombosis is a rare complication of nephritic syndrome, and there are only 5 case reports of this condition overall.
門靜脈栓塞也是其中之一，目前僅有五個病例報告。
Methods The ultrasonographic data of 12 cases of portal vein thrombosis after splenectomy were analyzed retrospectively.
方法回顧分析了12例患者，脾切除術后門靜脈系統血栓形成患者的超聲檢查資料。
The author introduces the routes, methods and efficacies of the interventional treatment via portal vein.
本文主要介紹了這些介入療法的途徑、方法及療效等情況。
The features of cirrhotic portal hypertension were within liver, larger in spleen and widen in portal vein.
肝硬化患者多數為肝臟縮小、脾大、門脈增寬。
Objective To observe the effect of hyperbaric oxygenation (HBO) on pre-operative preparation of portal vein hypertension.
目的觀察高壓氧（HBO）對門脈高壓癥患者術前準備的臨床療效。
Objective To observe the fetal blood flow changes in the liver portal vein system by color ultrasound Doppler.
目的應用多普勒超聲監測胎兒時期肝內門脈系統的血流參數。
To explore the role of color Doppler ultrasound in the diagnosis of fetal portal vein malformations.
目的探討彩色多普勒在胎兒門靜脈血管畸形應用中的價值。
